Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage

This study aims to analyze the neutralization ability against Omicron parental variants in five clusters of individuals with different Coronavirus disease (COVID-19) immunity backgrounds, including individuals receiving a homologous or heterologous vaccine without prior infection, recovered patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Szekely, Jidapa, Swangphon, Piyawut, Nanakorn, Natthaphon, Chaimuti, Panuttha, Nualnoi, Teerapat, Wongwitwichot, Paweena, Somapa, Namchoke, Somapa, Denpong, Pengsakul, Theerakamol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383937/
https://www.ncbi.nlm.nih.gov/pubmed/37515045
http://dx.doi.org/10.3390/vaccines11071230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383937/
https://www.ncbi.nlm.nih.gov/pubmed/37515045
http://dx.doi.org/10.3390/vaccines11071230

Ejemplares similares